Hansoh Pharmaceutical Group Company Limited Financial Overview
Hansoh Pharmaceutical Group Company Limited's market cap is currently HK$260.37B. The company's EPS TTM is HK$0.5820945533; its P/E ratio is 49.53; and it has a dividend yield of 0.85%. Hansoh Pharmaceutical Group Company Limited is scheduled to report earnings on August 18, 2025, and the estimated EPS forecast is HK$0.25. See an overview of income statement, balance sheet, and cash flow financials.
